Related Experiment Videos
[Consensus-recommendations for sirolimus in liver transplantation].
M Golling1, T Becker, C Broelsch
1Klinik für Allgemein- und Gefässchirurgie am Klinikum der Johann-Wolfgang-Goethe-Universität, Frankfurt am Main.
Zeitschrift Fur Gastroenterologie
|November 24, 2004
Summary
Sirolimus, an mTOR inhibitor, may offer benefits in liver transplantation due to its lack of renal side effects and potential anti-cancer properties. However, its use is restricted following reported complications, necessitating a review of its role in this context.
Area of Science:
- Immunosuppression and Oncology in Transplantation
- Pharmacology of mTOR Inhibitors
Background:
- Sirolimus (m-TOR inhibitor) exhibits potential benefits in liver transplantation, including renal safety and anti-malignancy effects.
- Limited use of Sirolimus in liver transplantation is attributed to documented complications and drug safety warnings.
- A consensus meeting convened to evaluate the existing literature on Sirolimus's role in liver transplant recipients.
Framework:
- The consensus statement adheres to standard guideline presentation, incorporating evidence grading (1a-5).
- Recommendations are categorized by extent (A-C), reflecting the strength of evidence and expert opinion.
- The framework integrates published literature with the authors' clinical experience in managing Sirolimus post-transplant.
Implementation:
- Literature analysis focused on Sirolimus's efficacy and safety specifically within the liver transplantation setting.
- Evidence grading was applied to systematically assess the quality and relevance of available studies.
- Clinical experience of authors was incorporated to provide practical insights into Sirolimus use.
Implications:
- This consensus provides guidance on the potential role of Sirolimus in liver transplantation, balancing benefits and risks.
- The findings aim to inform clinical practice regarding the appropriate use of Sirolimus in this patient population.
- Further research may be warranted to clarify the optimal application of Sirolimus in liver transplant management.